Laboratory of Neural Stem Cells and Functional Neurogenetics, Division of Neuroimmunology and Multiple Sclerosis, Columbus, OH, USA; Departments of Neurology and Neuroscience, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Laboratory of Neural Stem Cells and Functional Neurogenetics, Division of Neuroimmunology and Multiple Sclerosis, Columbus, OH, USA.
Semin Cell Dev Biol. 2019 Nov;95:84-92. doi: 10.1016/j.semcdb.2019.07.002. Epub 2019 Aug 16.
Human central nervous system (CNS) regeneration is considered the holy grail of neuroscience research, and is one of the most pressing and difficult questions in biology and science. Despite more than 20 years of work in the field of neural stem cells (NSCs), the area remains in its infancy as our understanding of the fundamental mechanisms that can be leveraged to improve CNS regeneration in neurological diseases is still growing. Here, we focus on the recent lessons from lower organism CNS regeneration genetics and how such findings are starting to illuminate our understanding of NSC signaling pathways in humans. These findings will allow us to improve upon our knowledge of endogenous NSC function, the utility of exogenous NSCs, and the limitations of NSCs as therapeutic vehicles for providing relief from devastating human neurological diseases. We also discuss the limitations of activating NSC signaling for CNS repair in humans, especially the potential for tumor formation. Finally, we will review the recent advances in new culture techniques, including patient-derived cells and cerebral organoids to model the genetic regulation of signaling pathways controlling the function of NSCs during injury and disease states.
人类中枢神经系统 (CNS) 的再生被认为是神经科学研究的圣杯,也是生物学和科学中最紧迫和最困难的问题之一。尽管在神经干细胞 (NSC) 领域已经开展了 20 多年的工作,但该领域仍处于起步阶段,因为我们对可以利用的基本机制的理解仍在不断发展,这些机制可以改善神经退行性疾病中的 CNS 再生。在这里,我们重点介绍了来自较低等生物 CNS 再生遗传学的最新发现,以及这些发现如何开始阐明我们对人类 NSC 信号通路的理解。这些发现将使我们能够更好地了解内源性 NSC 功能、外源性 NSCs 的效用,以及 NSCs 作为治疗载体为治疗毁灭性人类神经疾病提供缓解的局限性。我们还讨论了激活 NSC 信号以促进人类 CNS 修复的局限性,尤其是形成肿瘤的潜在风险。最后,我们将回顾新的培养技术的最新进展,包括患者来源的细胞和脑类器官,以模拟控制 NSCs 在损伤和疾病状态下功能的信号通路的遗传调控。